Dietary supplement industry-proposed drug-like GMPs advanced notice moving at FDA.
This article was originally published in The Tan Sheet
Executive Summary
FDA DIETARY SUPPLEMENT GMPs ANPR IN PROCESS of moving toward publication, Office of Special Nutritionals Director Elizabeth Yetley, PhD, suggested at the Food & Drug Law Institute annual educational conference Dec. 11. Yetley said "FDA is in the process of attempting to publish an Advance Notice of Public Rulemaking" concerning the use of drug-like Good Manufacturing Practices requirements for quality control issues relating to dietary supplements.